지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 저널정보
- 대한소아혈액종양학회 Clinical Pediatric Hematology-Oncology Clinical Pediatric Hematology-Oncology Vol.25 No.2
- 발행연도
- 2018.1
- 수록면
- 149 - 153 (5page)
이용수
초록· 키워드
오류제보하기
Background: Wiskott-Aldrich syndrome (WAS) is a very rare disease and patients who do not receive timely treatment suffer from bleeding, infection, and malignancy. Hematopoietic stem cell transplantation (HSCT) has been recognized as an effective treatment, but the standard transplantation protocol has not been established. We report the outcomes of WAS patients who underwent HSCT in our institution. Methods: We retrospectively studied patients who underwent HSCT at Seoul National University Children’s Hospital from 2005 to 2018. Busulfan-based myeloablative conditioning regimen was used, and an intensive daily therapeutic drug monitoring (TDM) for busulfan dosing was started for effective myeloablation and to reduce toxicity since 2008. We collected and analyzed data regarding symptoms, engraftment, transplantation-related toxicities, and survival. Results: Six WAS patients who received HSCT were evaluated. The median age of the patients at diagnosis was 5 years (range, 1-11). There were 2 matched unrelated donor bone marrow transplantations, 3 matched unrelated peripheral blood stem cell transplantations (PBSCT), and 1 haploidentical PBSCT. No patient experienced engraftment failure. Three patients developed grades II to IV acute graft-versus-host disease (GVHD). Two patients had veno-occlusive disease (VOD). Two patients died (due to VOD and acute GVHD). The 5-year overall survival was 66.7% with 8 years of median follow-up. Particularly, a patient who underwent haploidentical PBSCT using targeted busulfan is alive with a follow-up duration of 3 years after HSCT. Conclusion: In conclusion, WAS patients may be cured with HSCT with targeted busulfan-based myeloablative conditioning. But, long-term and multi-center studies are needed.
목차
등록된 정보가 없습니다.
참고문헌 (1)
참고문헌 신청
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Allogeneic hematopoietic stem cell transplantation in congenital hemoglobinopathies with myeloablative conditioning and rabbit anti-thymocyte globulin
Blood Research
2018 .01
-
조혈모세포 이식 환자의 불면증
생물치료정신의학
2018 .10
-
Ten-Year Trends of Hematopoietic Stem Cell Transplantation in Korean Pediatric Cancer from the National Health Insurance Claims Data
Cancer Research and Treatment
2024 .01
-
Comparison of the Clinical Outcomes Between Early and Delayed Transplantation After SARS-CoV-2 Infection
Journal of Korean Medical Science
2024 .04
-
Haploidentical hematopoietic stem cell transplantation in children and adolescents with acquired severe aplastic anemia
Clinical and Experimental Pediatrics
2015 .01
-
Blinatumomab as a Curative Therapy Option for Relapsed/Refractory Infant Acute Lymphoblastic Leukemia Post-Hematopoietic Stem Cell Transplantation - Case Report
Clinical Pediatric Hematology-Oncology
2024 .04
-
Early Left Ventricular Dysfunction in Children after Hematopoietic Stem Cell Transplantation for Acute Leukemia: A Case Control Study Using Speckle Tracking Echocardiography
Korean Circulation Journal
2015 .01
-
Anxiety and Depression of the Patients with Hematological Malignancies during Hospitalization for Hematopoietic Stem Cell Transplantation
PSYCHIATRY INVESTIGATION
2019 .01
-
조혈모세포 이식 전 환자의 사회적 지지, 희망, 불안 및 우울의 관계
성인간호학회지
2016 .02
-
Pre-transplant Dementia is Associated with Poor Survival After Hematopoietic Stem Cell Transplantation: A Nationwide Cohort Study with Propensity Score Matched Control
Clinical Psychopharmacology and Neuroscience
2021 .01
-
Acute Complications of Pediatric Allogeneic Hematopoietic Stem Cell Transplantation and Their Effects on Survival: A Single-Center Experience in Korea
Clinical Pediatric Hematology-Oncology
2023 .04
-
Haploidentical Family Donor Transplantation for Pediatric Hematologic Malignancies
Clinical Pediatric Hematology-Oncology
2021 .10
-
장의 급성 이식편대숙주병에서 대변미생물무리이식을 시행한 2예
대한내과학회지
2021 .08
-
Reduced-Intensity Conditioning with Busulfan and Fludarabine for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Lymphoblastic Leukemia
Yonsei Medical Journal
2020 .01
-
Clinical Experience of Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients Aged 60 Years and Older in South Korea
Yonsei Medical Journal
2023 .02
-
Long-term endocrine sequelae after hematopoietic stem cell transplantation in children and adolescents
Annals of Pediatirc Endocrinology & Metabolism
2024 .04
-
Association of FOXP3 Single Nucleotide Polymorphisms With Clinical Outcomes After Allogenic Hematopoietic Stem Cell Transplantation
Annals of Laboratory Medicine
2018 .01
-
Risk factors for mortality in patients with bloodstream infections during the pre-engraftment period after hematopoietic stem cell transplantation
Blood Research
2016 .01
-
How I Treat Primary Immune Deficiencies with Hematopoietic Stem Cell Transplantation
Clinical Pediatric Hematology-Oncology
2022 .10
이 논문의 저자 정보
최근 본 자료
댓글(0)
0